Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
412 hedge funds and large institutions have $6.25B invested in Abiomed Inc in 2020 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 150 increasing their positions, 155 reducing their positions, and 93 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 155
11% less funds holding
Funds holding: 465 → 412 (-53)
17% less capital invested
Capital invested by funds: $7.55B → $6.25B (-$1.3B)
49% less call options, than puts
Call options by funds: $81.4M | Put options by funds: $158M
52% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 93
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$171M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$92.7M |
| 3 |
DM
Deerfield Management
New York
|
+$62.4M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$35.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$34.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sands Capital Management
Arlington,
Virginia
|
-$163M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$119M |
| 3 |
HM
HealthCor Management
New York
|
-$48.9M |
| 4 |
Renaissance Technologies
New York
|
-$45.7M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$45.5M |
ABMD Hedge Fund Activity: Q1 2020 in Review
412 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2020, worth a combined $6.25B — down 17% from $7.55B a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of ABMD and 45 opened new positions — a net loss of 48 holders — while 155 trimmed existing stakes and 150 added.
The largest buyer was Wellington Management Group, adding an estimated $171M. The largest seller was Sands Capital Management, cutting an estimated $163M.
- 412 institutional investors held Abiomed Inc (ABMD) as of Q1 2020, down from 465 in Q4 2019.
- Funds reported $6.25B of Abiomed Inc stock for Q1 2020, down 17% quarter-over-quarter.
- 45 funds opened new Abiomed Inc positions in Q1 2020 and 93 closed out, a net change of -48 holders.
- The largest Abiomed Inc buyer in Q1 2020 was Wellington Management Group, an estimated $171M added.
- The largest Abiomed Inc seller in Q1 2020 was Sands Capital Management, an estimated $163M sold.
Based on aggregated 13F filings for Q1 2020.